Genetically Modified Host Cells for L-DOPA Oxidation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing oxidized products of aromatic amino acids, such as L-DOPA, face challenges including slow microbial conversion and over-oxidation issues due to the lack of tetrahydrobiopterin (BH4) cofactor in microbial systems, which limits the efficiency and specificity of tyrosinase-based processes.
Innovation Solution
Genetically modified host cells, like E. coli, are engineered to express mouse tyrosine hydroxylase and include BH4 regeneration pathways, allowing for the production of L-DOPA with minimized overoxidation by using tetrahydromonapterin (MH4) as an alternative cofactor, enabling efficient oxidation of tyrosine to L-DOPA and subsequent production of other aromatic compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If tyrosinase is used for microbial L-DOPA production, then the process can be performed under mild conditions with high regioselectivity, but the conversion speed is slow and over-oxidation to ortho-quinone is difficult to avoid
Solution Approach 1:
The patent changes the cofactor parameter from the natural BH4 (which is unavailable in microbes) to tetrahydromonapterin (MH4), a structurally similar alternative that can be synthesized by microbial cells. This parameter substitution enables the use of tyrosine hydroxylase in microbial systems while maintaining catalytic efficiency and preventing over-oxidation, thus resolving both the selectivity and productivity issues.
2Ease of operation
If tyrosinase is used for L-DOPA production, then the reaction proceeds under mild conditions, but over-oxidation to ortho-quinone occurs and requires additional purification steps
Solution Approach 1:
By substituting the cofactor parameter to MH4 and engineering the microbial expression system to produce it, the patent achieves controlled oxidation that prevents over-oxidation side reactions. This eliminates the need for additional purification steps involving reducing agents, thereby maintaining ease of operation while reducing process complexity.
3Reliability
If tetrahydrobiopterin (BH4) is used as cofactor for tyrosine hydroxylase, then over-oxidation is prevented, but BH4 is unavailable in microbial systems
Solution Approach 1:
The patent replaces the expensive and unavailable BH4 cofactor with MH4, which can be synthesized de novo by microbial cells using endogenous metabolic pathways. This substitution makes the system adaptable to microbial hosts while maintaining the specificity and reliability of the oxidation reaction, as MH4 performs the same cofactor function without requiring external supplementation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the production of L-DOPA and other aromatic compounds with improved yield and specificity, overcoming the limitations of traditional microbial methods by utilizing alternative cofactors and regeneration pathways in genetically modified host cells.
Implementation Method 1
The host cell comprises an enzyme capable of catalyzing the oxidation of aromatic amino acid
Implementation Method 2
hydroxylation of aromatic ring by microorganisms is an interesting and promising method to synthesize the desired products
Implementation Method 3
Microbial aromatic hydroxylation is involved in the aerobic metabolism of aromatic compounds and mostly performed by oxygenases and tyrosinases
Implementation Method 4
The use of pterin cofactor during the oxidation step is unique feature of TH and related enzyme such as phenylalanine hydroxylase (PAH) and tryptophan hydroxylase (TPH)
Data Source
AI summary
The present invention provides for a method of producing an oxidation product of an aromatic amino acid in a genetically modified host cell. The method comprises culturing the genetically modified host cell under a suitable condition such that the culturing results in the genetically modified host cell producing oxidation product of an aromatic amino acid. The host cell comprises an enzyme capable of catalyzing the oxidation of aromatic amino acid. In some embodiments, the host cell is capable of biosynthesizing BH4 or MH4 from GTP.